Replies to post #159197 on Biotech Values

[DewDiligence]

Merz decides to let VRX have OMPI, showing the discipline you’d expect from a private, family-run company:

http://www.merz.com/press/pressreleases/company_2/detail_1280.jsp?source=pmov&tabId=1

OMPI isn’t worth more than the $22/sh Merz offered last week (#msg-86332513), IMO.